HSP27 is a partner of JAK2-STAT5 and a potential therapeutic target in myelofibrosis
Myelofibrosis is a chronic degenerative disorder characterized by progressive bone marrow fibrosis. Here, the authors show that the chaperone HSP27 contributes to myelofibrosis via regulation of the JAK2/STAT5 pathway, and that antisense oligonucleotides targeting HSP27 are effective in two mouse mo...
Enregistré dans:
Auteurs principaux: | Margaux Sevin, Lucia Kubovcakova, Nicolas Pernet, Sébastien Causse, Franck Vitte, Jean Luc Villeval, Catherine Lacout, Marine Cordonnier, Fernando Rodrigues-Lima, Gaétan Chanteloup, Matthieu Mosca, Marie-Lorraine Chrétien, Jean Noël Bastie, Sylvain Audia, Paul Sagot, Selim Ramla, Laurent Martin, Martin Gleave, Valérie Mezger, Radek Skoda, Isabelle Plo, Carmen Garrido, François Girodon, Aurélie de Thonel |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2018
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/7cd28d8985ce47f7a61f528b7a0f931b |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Recent developments in myelofibrosis
par: Mesa RA, et autres
Publié: (2012) -
Ruxolitinib as an emerging treatment in myelofibrosis
par: Emanuel RM, et autres
Publié: (2013) -
Evidence that prefibrotic myelofibrosis is aligned along a clinical and biological continuum featuring primary myelofibrosis.
par: Giovanni Barosi, et autres
Publié: (2012) -
Simultaneous hepatosplenic T-cell lymphoma and myelofibrosis
par: Ali M Gabali, et autres
Publié: (2014) -
New Markers of Disease Progression in Myelofibrosis
par: Rita Campanelli, et autres
Publié: (2021)